The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of pyrotinib combined with trastuzumab emtansine (T-DM1) for patients with advanced HER2-positive breast cancer (BC): A single-arm phase II trial.
 
Chunfang Hao
No Relationships to Disclose
 
Xiaowei Qi
No Relationships to Disclose
 
Yehui Shi
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Jie Zhang
No Relationships to Disclose
 
Wenjing Meng
No Relationships to Disclose
 
Xiaonan Yang
No Relationships to Disclose